clinical trial · NCT06485206
Evaluation of Safety and Effectiveness of Primary Hybrid Construct of Mobi-C and ACDF in the Treatment of Two-level Symptomatic Degenerative Disc Disease in the Cervical Spine.
Highridge Medical·N/A·recruiting·n = 97
Degenerative Disc DiseaseOne level Mobi-C and one level fusion
brief summary
The study is a prospective, multi-center cohort study of patients with two-level DDD implanted with CDA adjacent to ACDF (hybrid construct). The overall success of the hybrid procedure will be compared to 2-level ACDF historical controls from the Mobi-C IDE trial. 97 patients will receive the hybrid surgery and will be followed for a minimum of 2 years.
started
Sep 1, 2024
primary completion
May 1, 2029
completion
May 1, 2029
last updated
Jan 27, 2025
official title
A Clinical Investigation Evaluating Safety and Effectiveness of Primary Hybrid Construct of Mobi-C and ACDF in the Treatment of Two-level Symptomatic Degenerative Disc Disease in the Cervical Spine.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol